Simulations Plus, Inc.
SLPHealthcareNASDAQHealth Information Services
Scan Results
Daily timeframeHeadquartered within the healthcare sector, Simulations Plus, Inc. focuses on Health Information Services services and products. Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The $368.7M market capitalization puts SLP squarely in small-cap range for its industry. It operates through Software and Services segments.
Market Cap
$368.7M
Beta
1.31
P/E (TTM)
45.58
P/E (Fwd)
20.66
EPS (TTM)
$0.40
EPS (Fwd)
$0.88
ROE
6.2%
ROA
5.5%
Cash
$50.0M
Total Debt
$487,000
Free CF
$18.4M
52W Change
46.3%
Annual Financials
Cash vs Debt
With $50.0M in cash and $487K in debt, SLP maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Free cash flow comes in at $18.4M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 6.2% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 5.5% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $53.9M (2022) to $79.2M (2025), reflecting a 47% increase over the period.
The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing SLP.